Sunday, March 17, 2013 Saturday, March 16, 2013 Friday, March 15, 2013- Time In, Not Timing Dividend Growth Stocksat Seeking Alpha (Fri, Mar 15)
- Better Biotech Buy: Biogen vs. Celgeneat Motley Fool (Fri, Mar 15)
- This Defensive Growth Favorite Updates Guidanceat Motley Fool (Fri, Mar 15)
- 4 Key Drug Approvals Expected In The Next 30 Daysat Investor's Business Daily (Fri, Mar 15)
- Three Smart Money Dividend Companiesat Motley Fool (Fri, Mar 15)
- How Will Medical Device Companies Fare in the New Health Care Environment?Wall Street Transcript (Fri, Mar 15)
- Cisco Systems, A Strong Buy For Multiple Reasonsat Seeking Alpha (Fri, Mar 15)
- Sell Johnson & Johnson As It Is Over Extendedat Seeking Alpha (Fri, Mar 15)
- Can Johnson & Johnson Hold Its Momentum?at Motley Fool (Fri, Mar 15)
- [video] Bond Bull Market 'Is Done': Harvey Eisenat CNBC (Fri, Mar 15)
Thursday, March 14, 2013- 5 Reasons We Stink As Investorsat Seeking Alpha (Thu, Mar 14)
- Does Johnson & Johnson's Dividend Have Room to Soar?at Motley Fool (Thu, Mar 14)
- Walgreen: Should I Stay Or Should I Go Now?at Seeking Alpha (Thu, Mar 14)
- 4 Healthcare Stock Stories for Thursday Investment Wellnessat Wall St. Cheat Sheet (Thu, Mar 14)
- How To Find Satisfaction With Your Investmentsat Seeking Alpha (Thu, Mar 14)
- 2 Reasons Why Income Investors Should Ignore Warren Buffett's Dividend Argumentat Seeking Alpha (Thu, Mar 14)
- These 2 Billionaire Stock Picks Are Cheap And Worth Buying Nowat Seeking Alpha (Thu, Mar 14)
- Better Health, an iPhone App Awayat Motley Fool (Thu, Mar 14)
- How A Blue-Chip Dividend Strategy Can Failat Seeking Alpha (Thu, Mar 14)
- S&P 500 all-time high stocks most since 2004: Birinyiat MarketWatch (Thu, Mar 14)
Add JNJ News to My Yahoo!  | |
|